# A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes

> **NCT04050670** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 54 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tirzepatide

## Key facts

- **NCT ID:** NCT04050670
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-13
- **Primary completion:** 2020-04-03
- **Final completion:** 2020-04-03
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2023-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04050670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04050670, "A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04050670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*